Why Novartis Missed Wall Street Q1 Estimates
Novartis (NYSE: NVS) hasn't given investors much to cheer about over the last year. Its shares have gone in the wrong direction over the last 12 months and so far in 2021.
The big drugmaker announced its first-quarter results before the market opened on Tuesday. And there still wasn't much to cheer about, with the pharma stock slipping more than 1% in early trading. Here are the highlights from Novartis' Q1 update.
Image source: Getty Images.
Source Fool.com
